Everolimus for cognition/autism in children with tuberous sclerosis complex: Definitive outcomes deferred

Neurology. 2019 Jul 9;93(2):51-52. doi: 10.1212/WNL.0000000000007744. Epub 2019 Jun 19.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Autistic Disorder*
  • Child
  • Cognition
  • Everolimus
  • Humans
  • Immunosuppressive Agents
  • Tuberous Sclerosis*

Substances

  • Immunosuppressive Agents
  • Everolimus